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ABSTRACT
Introduction Infectious disease models are important
tools to inform public health policy decisions. These
models are primarily based on an average population
approach and often ignore the role of social determinants
in predicting the course of a pandemic and the impact
of policy interventions. Ignoring social determinants
in models may cause or exacerbate inequalities. This
limitation has not been previously explored in the context
of the current pandemic, where COVID-19 has been found
to disproportionately affect marginalised racial, ethnic and
socioeconomic groups. Therefore, our primary goal is to
identify the extent to which COVID-19 models incorporate
the social determinants of health in predicting outcomes of
the pandemic.
Methods and analysis We will search MEDLINE,
EMBASE, Cochrane Library and Web of Science databases
from December 2019 to August 2020. We will assess
all infectious disease modelling studies for inclusion of
social factors that meet the following criteria: (a) focused
on human spread of SARS-CoV-2; (b) modelling studies;
(c) interventional or non-interventional studies; and (d)
focused on one of the following outcomes: COVID-19-
related outcomes (eg, cases, deaths), non-COVID-19-
related outcomes (ie, impacts of the pandemic or control
policies on other health conditions or health services), or
impact of the pandemic or control policies on economic
outcomes. Data will only be extracted from models
incorporating social factors. We will report the percentage
of models that considered social factors, indicate which
social factors were considered, and describe how social
factors were incorporated into the conceptualisation and
implementation of the infectious disease models. The
extracted data will also be used to create a narrative
synthesis of the results.
Ethics and dissemination Ethics approval is not required
as only secondary data will be collected. The results of
this systematic review will be disseminated through peer-
reviewed publication and conference proceedings.
PROSPERO registration number CRD42020207706.

INTRODUCTION
In the early months of the pandemic,
COVID-19 was described by New York
Governor Andrew Cuomo as the ‘great equaliser’1 as the new coronavirus swept through
society without bias. A shared lack of immunity meant that regardless of prestige, wealth,

Strengths and limitations of this study
►► The Preferred Reporting Items for Systematic Review

and Meta-Analysis Protocols will be followed.
►► A systematic approach to evaluating modellers’ in-

corporation of social factors into COVID-19 models
will identify practical approaches to better quantify
social inequities of the pandemic and predict the impact of public policies on marginalised populations.
►► Included studies of COVID-19 models may not be
amenable to quantitative synthesis due to heterogeneity of the literature.
►► Given the time frame of the search strategy and the
rapid evolution of COVID-19 modelling literature, the
results may not include studies evaluating certain
prevention strategies, such as vaccination.

fame or age, all were thought to be equally at
risk.1 However, epidemiological researchers
quickly demonstrated that this was, and
remains to be, far from the truth. The
pandemic has put existing health inequalities
under the microscope and highlighted that
COVID-19 has disproportionately affected
marginalised racial, ethnic, and socioeconomic groups through its unequal health
burden and its disparity of economic losses.2 3
A recent investigation found that among 158
counties in large US metropolitan areas,
those with predominantly non-white populations had infection rates approximately eight
times higher, and a fatality rate more than
nine times higher than counties with a mostly
white population.4 Similarly, people living
in the poorest neighbourhoods of England
and Wales have been found to be twice as
likely to die from COVID-19 as those in more
affluent areas.5 Examples of similar trends
can be found throughout history. Perhaps
most notably in terms of size and scale, data
collected from the 1918 influenza pandemic
demonstrated that non-white minorities had
higher all-
cause mortality and influenza-
related mortality rates when compared with
their white counterparts.6 These disparities
are a symptom of deeper societal and health
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incorporate the social determinants of health?’ Our objective is to systematically review human COVID-19 modelling studies (predictive, forecasting) to identify what
proportion of models incorporate social factors and for
included modelling studies, to identify how social factors
were incorporated into the conceptualisation of the infectious disease models. The work will provide an important
reflection on COVID-19 modelling practices and can lead
to development of a blueprint for other modellers to
incorporate social factors in the future. We hope that this
review will lead to infectious disease models that explicitly
acknowledge the role of social determinants in making
better predictions as well as mitigating inequalities, and
therefore result in better infectious disease outcomes.

METHODS
Protocol and registration
This systematic review will be conducted according to the
Preferred Reporting Items for Systematic Reviews and
Meta-analyses guidelines22 for the identification, screening,
eligibility and inclusion of retrieved research studies. The
current protocol is registered in the International Prospective Register of Systematic Reviews.23 The anticipated start
date for the proposed systematic review is November 2020.
The full results will be submitted for peer-reviewed publication immediately following completion of quality assessment
and the drafting of a manuscript in August 2021.
Search strategy and eligibility criteria
MEDLINE, EMBASE, Cochrane Library and Web of
Science databases will be searched. The present systematic review is designed to have broad eligibility criteria to
identify all COVID-19 modelling studies published from
December 2019 to 14 August 2020. Studies will be initially
eligible if they: (1) have a human SARS-CoV-2 population; (2) are a modelling study (eg, mechanistic, mathematical, network, simulation, auto-regressive, Markov or
other model); and (3) investigate one of the following
outcomes: COVID-19 disease-related outcomes (eg, cases,
hospitalisations, deaths, recoveries), non-
COVID-19
related outcomes (eg, impact on other health
disease-
conditions such as mental health), impacts on health
services (eg, bed occupancy, ventilators, surgical delays),
impact of policies (eg, lockdowns, social distancing) or
interventions (vaccines, treatments, etc) on COVID-19 or
societal outcomes. Eligible studies will then be assessed
for components of social determinants. This will allow the
research team to calculate the percentage of COVID-19
modelling studies that incorporated social determinants into their predicted outcomes of the pandemic
(ie, studies that included social factors (numerator) and
all eligible studies (denominator)). Data will only be
extracted from models that included social determinants.
The following studies will be excluded: (1) within-host
biological studies, (2) non-human SARS-CoV-2 studies,
(3) phylogenic/genetic studies, (4) environmental/
meteorological studies without health impact analysis on
John-Baptiste A, et al. BMJ Open 2021;11:e048995. doi:10.1136/bmjopen-2021-048995
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system inequities, including disproportionate exposure
through high-risk jobs, prevalence of comorbidities, and
inequitable access to testing and treatment.
Over the past century, infectious disease models have
played a fundamental role in helping public health policymakers implement infection control interventions, as
well as shape the theories used in disease mitigation.7
Infectious disease models have been described as, ‘a
scientific approach to formulating an explanation for an
observed phenomenon and then testing this formulation
to project the outcome of various experiments under
pertinent conditions’8 (p1). Models provide a framework
for experts to study a number of important factors related
to the SARS-CoV-2 pandemic, including the following:
1. Viral transmission dynamics—models use observed
data such as the number of confirmed cases, to estimate difficult-to-observe transmission dynamics, such
as the incubation period and percentage of asymptomatic spread in the population.9 10
2. Anticipate the future course of an outbreak—models
forecast future incidence, prevalence, morbidity and
mortality, based on input parameters.11 12
3. Guide public health planning and infectious disease
control—models help researchers simulate real-world
possibilities and thus appraise the potential impact of
disease-control strategies such as mask wearing, school
closures, testing and contract-tracing on the population.13 14
4. Models can estimate a range of outcomes, those directly related to COVID-19 or secondary effects of the
disease and control measures, on population health,
health service utilisation, and economic outcomes
such as cost and quality of life.15
Infectious disease models can only be fit for purpose
if the models are appropriately conceptualised and
model parameters are based on the best available
evidence.16 17 Model conceptualisation requires decisions
about the model structure, including which health states
to include, division of the population into subgroups and
selection of characteristics to define the subgroups.16
Thus, models can incorporate the social determinants
of health,18 such as income, education, employment and
ethnicity. However, structuring models to reflect social
determinants increases complexity and sometimes, due
to limited availability of data, raises questions about structural uncertainty.19 20 Complexity and uncertainty may
lead modellers to simplify and favour average population
models foregoing appraisal of different types of individuals or important subgroups.19–21 Current evidence
highlights the importance of social factors in predicting
the course of the pandemic and in analyses of policy
options,2–6 although it is unclear to what extent current
infectious disease models are based on an average population approach and ignore social factors. To the best of
our knowledge, this limitation has yet to be explored in
the context of the COVID-19 pandemic. Therefore, the
present systematic review will aim to answer the following
research question: ‘To what extent do COVID-19 models
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MEDLINE search strategy (4 August 2020)

1. coronavirus/ or betacoronavirus/ or coronavirus infections/ (20740)
2. (“coronavirus*” or “coron?virinae*” or “novel coronavirus*” or
“novel corona virus” or “Severe Acute Respiratory Syndrome
Coronavirus 2” or “coronavirus disease 2019” or “coronavirus
pandemic?” or “coronavirus epidemic?” or “coronavirus outbreak?” or “corona virus pandemic?” or “corona virus epidemic?”
or “corona virus outbreak?” or “corona virus disease 2019” or
“new coronavirus” or “new corona virus*” or “new coronaviruses”
or “novel coronaviruses” or “2019 ncov” or “nCov 2019” or “SARS
Coronavirus 2” or “2019-nCoV” or “2019nCoV” or “2019-CoV”
or “nCoV2019” or “nCoV-2019” or “COVID-19” or “COVID-19” or
“CORVID-19” or “CORVID19' or WN-CoV or WNCoV'” or “HCoV-19”
or “HCoV19” or “CoV " or "2019 novel*” or “Ncov” or “nCov” or “n-
cov” or “SARSCoV-2” or “SARSCoV-2” or “SARSCoV2” or “SARS-
CoV2” or “SARS-COV-2” or “SARSCov19” or “SARS-Cov19” or
“SARSCov-19” or “SARS-Cov-19” or “SARSr-cov” or “Ncovor” or
“Ncorona*” or “Ncorono*” or “NcovWuhan*” or “NcovHubei*” or
“NcovChina*” or “NcovChinese*” or “Wuhan virus*” or “novel CoV”
or “CoV 2” or “CoV2” or “betacoron?vir*").mp. (54405)
3. ((corona* or corono*) adj1 (virus* or viral* or virinae*)).mp. (1032)
4. (((respiratory* adj2 (acute* or symptom* or disease* or illness* or
infect* or condition*)) or “sea-food market*” or “seafood market*”
or “food market*” or “foodmarket*” or “wet market*” or “wet-
market*” or “wetmarket*") adj10 (Wuhan* or Hubei* or China* or
Chinese* or Huanan*)).mp. (1479)
5. ((outbreak* or wildlife* or wild-life or pandemic* or epidemic* or
coronavirus or corona virus) adj3 (Wuhan* or Hubei* or China* or
Chinese* or Huanan*)).mp. (2228)
6. (anti-flu* or anti-influenza* or antiflu* or antinfluenza*).mp. (3379)
7. or/1–6 (60113) - (All Coronavirus / COVID-19 Terms)
8. Models, Theoretical/ (150928)
9. Models, Biological/ (338438)
10. Stochastic Processes/ or stochastic.mp. (44593)
11. (forecast* or model* or simulat*).af. (4238913)
12. or/8–11 (4250384) - (All Model Terms)
13. 7 and 12 (6971) - (All Coronavirus/COVID-19 Terms) AND (All
Model Terms)
14. transmi*.ti,kf. (110754)
15. 7 and 14 (1788)—(Result Set to capture a non-COVID-19 paper)
16. 13 or 15 (8442)
17. (“32691014” or “32689711” or “32171948” or “32687538” or
“32685697” or “32685143” or “32673577” or “32660125” or
“32546824” or “32372755” or “32246905” or “32325039” or
“32444481” or “32269020” or “32245814” or “32632012” or
“22999128” or “22990082” or “31422772” or “28577700” or
“24034486” or “32691015” or “32690354” or “32680824” or
“32298421” or “22999128” or “22990082” or “22999132” or
“31422772” or “28577700” or “24034486”).ui. (26)
18. 13 and 17 (20)
19. limit 16 to yr=“2019 -Current” (4850)—(Final Result Set)

humans, (5) epidemiological/statistical analyses without
a model, and (6) economic analyses without a model. An
example search strategy can be found in box 1.
Review process
After executing the search strategy, articles will be
uploaded to Covidence software (v2619 b264f491)
and duplicates will be removed. Titles and/or abstracts
John-Baptiste A, et al. BMJ Open 2021;11:e048995. doi:10.1136/bmjopen-2021-048995

of the articles will be screened independently by two
review members to identify studies that potentially meet
the inclusion criteria outlined above. Conflicts will be
resolved by a third independent reviewer. The full texts
of these potentially eligible studies will then be retrieved
and independently assessed for eligibility by two review
team members. Any disagreements between them over
the eligibility of particular studies will be resolved by a
third reviewer. Data will then be extracted from the
studies that incorporated social factors. A flow chart for
this systematic review can be found in figure 1.
Data extraction and quality assessment
Data will be extracted into Covidence by one reviewer
and confirmed by a second reviewer. Disagreements
will be resolved with a discussion between the two
reviewers and if necessary, the final decision will
be made by a third reviewer. If data related to the
outcomes are missing, this will be reported. Authors
will not be contacted to request missing data. The
following data will be extracted from included studies:
author, publication year, geography (country, province/state, city/town, region, low/middle/high-
income country), setting (eg, general population,
long-term care home, hospital, workplace, etc), population size, goals (predicting the pandemic, impact on
other health conditions, impact on health services,
impact of policy or interventions, economic analyses),
type of model (mathematical, mechanistic, etc), social
and economic factors, and approach to incorporating
social and economic factors. An example extraction
table containing the characteristics of included studies
in the systematic review can be found in table 1.
There is currently no standardised tool for assessing
the quality of infectious disease modelling studies.
We plan to adapt the principles of best practices for
infectious disease modelling, laid out by Pitman et al
into a tool for quality assessment of infectious disease
models.24
Evidence synthesis
The extracted data will be used to create a narrative
synthesis of the results. Based on our broad inclusion
criteria, it is likely that the study designs and data will be
too heterogeneous for meta-analyses to be appropriate.
We expect to report on the number (per cent) of identified infectious disease models that incorporated social
factors. We will report on the social factors considered,
and indicate the number (per cent) of included models
that considered each social factor. The narrative synthesis
will describe how social factors were incorporated into the
conceptualisation of the infectious disease models, estimate policy impact across social groups (if relevant) and
describe which model types (eg, compartmental, network
models) were used when social factors were considered.
We will compare models in terms of the approaches used
to incorporate social factors; identify trends and see if an
increasing number of published models incorporated
3
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Box 1

Open access

Records identified
through
additional sources
(n = )

Records after duplicates
removed
(n = )

Records excluded
based on title and
abstract
(n = )

Full-text articles assessed
for eligibility
(n = )

Full-text articles excluded
(n = )
Reasons for Exclusion
1) Non-human study (n = )
2) Non-modelling study (n = )
3) Unrelated outcomes (n = )

Human COVID-19
modelling studies
(n = )

Included studies that
incorporated social factors
(n = )

Figure 1

Flow diagram of selection criteria.

DISCUSSION
To the best of our knowledge, this will be the first
systematic review that aims to identify the frequency and
approach used in COVID-19 models to incorporate the

social factors over time; and based on our knowledge
of published epidemiological estimates that quantify
the association between social factors and COVID-19,25
compare incorporation of social factors in COVID-19
models to this evidence base.

Table 1 Dummy extraction table—characteristics of included studies
Author(s)

Month/
year
Geography

Setting

N

Smith et al

March
2020

Milan,
Italy
High income

Hospital

400

Jones et al

April
2020

Wuhan,
China
High income

General

2000

Harrison et al

May
2020

Seattle,
USA
High income

Long-term
care

300

Approach to
social factors

Goal(s)

Model type

Social factors

Predicting the
pandemic
Case fatality

Compartmental

Income
Employment

TBD

Impact of policy or
intervention
Lockdown

Network

Education

TBD

Impact on other health
conditions
Mental health

Mechanistic

Employment

TBD

TBD, To be determined.
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Records identified through MEDLINE (n = ),
Embase (n = ), Cochrane Library (n = ),
Web of Science (n = ) database searching
(N = )
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motivate enhancements in modelling best practices,
and ultimately improve health for socially and economically vulnerable groups related to COVID-19 and other
health conditions.
Ethics and dissemination
Ethical approval is not required as only secondary data
will be collected. The results of this systematic review will
be disseminated through peer-reviewed publication and
conference proceedings.
Contributors AJ-B and SA secured the funding, designed the review, drafted the
paper and approved the final version to be published. MM wrote the paper and
approved the final version to be published.
Funding This project is funded by the Gordon and Betty Moore Foundation through
grant GBMF9634 to Johns Hopkins University to support the work of the Society for
Medical Decision Making COVID-19 Decision Modeling Initiative.
Competing interests None declared.
Patient and public involvement Patients and/or the public were not involved in
the design, or conduct, or reporting, or dissemination plans of this research.
Patient consent for publication Not required.
Provenance and peer review Not commissioned; externally peer reviewed.
Open access This is an open access article distributed in accordance with the
Creative Commons Attribution Non Commercial (CC BY-NC 4.0) license, which
permits others to distribute, remix, adapt, build upon this work non-commercially,
and license their derivative works on different terms, provided the original work is
properly cited, appropriate credit is given, any changes made indicated, and the use
is non-commercial. See: http://creativecommons.org/licenses/by-nc/4.0/.
ORCID iD
Marc S Moulin http://orcid.org/0000-0001-6654-4914

REFERENCES

1 Mein SA. COVID-19 and Health Disparities: the Reality of "the Great
Equalizer". J Gen Intern Med 2020;35:2439–40.
2 Ali S, Asaria M, Stranges S. COVID-19 and inequality: are we all in
this together? Can J Public Health 2020;111:415–6.
3 Williams DR, Cooper LA. COVID-19 and Health Equity-A New Kind of
"Herd Immunity". JAMA 2020;323:2478–80.
4 Adhikari S, Pantaleo NP, Feldman JM, et al. Assessment of
community-level disparities in coronavirus disease 2019 (COVID-19)
infections and deaths in large US metropolitan areas. JAMA Netw
Open 2020;3:e2016938
5 Caul S. Deaths involving COVID-19 by local area and socioeconomic
deprivation: deaths occurring between 1 March and 31 July 2020.
Statistical Bulletin 2020.
6 Hutchins SS, Fiscella K, Levine RS, et al. Protection of racial/ethnic
minority populations during an influenza pandemic. Am J Public
Health 2009;99 Suppl 2:S261–70.
7 Lessler J, Cummings DAT. Mechanistic models of infectious disease
and their impact on public health. Am J Epidemiol 2016;183:415–22.
8 Star L, Moghadas SM. The role of mathematical modelling in
public health planning and decision making. Purple Paper, National
Collaborative Center for Infectious Diseases 2010.
9 Zhou L, Liu J-M, Dong X-P, et al. COVID-19 seeding time and
doubling time model: an early epidemic risk assessment tool. Infect
Dis Poverty 2020;9:1–9.
10 Tuite AR, Fisman DN, Reporting FDN. Reporting, epidemic growth,
and reproduction numbers for the 2019 novel coronavirus (2019-
nCoV) epidemic. Ann Intern Med 2020;172:567–8.
11 Wang Y, Xu C, Yao S, et al. Forecasting the epidemiological trends
of COVID-19 prevalence and mortality using the advanced α-Sutte
Indicator. Epidemiol Infect 2020;148:e236.
12 Ogden NH, Fazil A, Arino J. Artificial intelligence in public health:
modelling scenarios of the epidemic of COVID-19 in Canada. Can
Commun Dis Rep 2020;46:198–204.
13 Fisman DN, Greer AL, Tuite AR. Bidirectional impact of imperfect
mask use on reproduction number of COVID-19: a next generation
matrix approach. Infect Dis Model 2020;5:405–8.

5

BMJ Open: first published as 10.1136/bmjopen-2021-048995 on 5 July 2021. Downloaded from http://bmjopen.bmj.com/ on January 7, 2022 by guest. Protected by copyright.

social determinants of health to predict outcomes of
the pandemic. Despite previous research and adequate
knowledge of the disproportionate health burden
experienced by marginalised groups, we hypothesise
that the majority of COVID-19 models continue to
ignore these important social factors. Without taking
into account the influences of unequal levels of exposure, vulnerability and inequitable access to health
services dictated by social factors,26 COVID-19 models
may be providing an unclear illustration of the impact
of COVID-19 and disease-control efforts. When health
system decision-makers use average population-based
models to implement large-scale health policies, they
may be unintentionally exacerbating existing health
inequities and leaving these marginalised groups
further behind. Furthermore, failure to incorporate
social factors may lead to missed opportunities to
appraise targeted interventions to overcome inequities in the impact of COVID-19. Indeed, interventions
targeted towards marginalised groups may prove more
efficient for controlling the pandemic than interventions at the population level. Although our primary
goal is to systematically document the scientific literature, our secondary goal with this review is to identify
modellers that have incorporated social factors into
the conceptualisation of their COVID-19 models, and
detail the approach they used to do so. It is plausible
that exclusion of social factors from COVID-19 models
is not a result of neglect, but due to time constraints
and limited computational power to handle increased
model complexity. The modelling community is highly
specialised and their skill sets are coveted by a range
of policy decision-makers. Thus, modellers can have
significant influence over policy decision-
making
processes. If modellers increase the awareness of the
need to incorporate social factors into COVID-19
models, constraints on incorporating social factors
into models can potentially be overcome through
increased investments in computer infrastructure
and strategic collaboration among modelling groups.
It is our hope that this review will help to provide a
preliminary roadmap for modellers to incorporate
social factors into future COVID-19 models, and subsequently result in better health outcomes for the entire
population.
The proposed systematic review will likely be limited
by the rapidly evolving nature of the COVID-19 modelling literature. Given the time frame of the search
strategy, we will likely not find many studies evaluating
vaccination strategies. However, the findings on incorporating social factors into infectious disease models
will still be relevant to modellers working on vaccine
policy appraisal.
The strengths of the proposed review are that a
systematic approach to evaluating modellers’ incorporation of social factors into COVID-19 models can identify practical approaches to making better predictions
and reduce inequities, quantify gaps in the literature,

Open access

6

20 Jain R, Grabner M, Onukwugha E. Sensitivity analysis in cost-
effectiveness studies. Pharmacoeconomics 2011;29:297–314.
21 Sculpher M. Subgroups and heterogeneity in cost-effectiveness
analysis. Pharmacoeconomics 2008;26:799–806.
22 Moher D, Shamseer L, Clarke M, et al. Preferred reporting items for
systematic review and meta-analysis protocols (PRISMA-P) 2015
statement. Syst Rev 2015;4:1.
23 Booth A, Clarke M, Dooley G, et al. The nuts and bolts of Prospero:
an international prospective register of systematic reviews. Syst Rev
2012;1:1–9.
24 Pitman R, Fisman D, Zaric GS, et al. Dynamic transmission modeling:
a report of the ISPOR-SMDM modeling good research practices Task
force working Group-5. Med Decis Making 2012;32:712–21.
25 Upshaw TL, Brown C, Smith R, et al. Social determinants of
COVID-19 incidence and outcomes: a rapid review. PLoS One
2021;16:e0248336.
26 Moloughney BW. Social determinants of health: what can public
health do to address inequities in infectious disease? Can Commun
Dis Rep 2016;42:S1-14–S1-17.

John-Baptiste A, et al. BMJ Open 2021;11:e048995. doi:10.1136/bmjopen-2021-048995

BMJ Open: first published as 10.1136/bmjopen-2021-048995 on 5 July 2021. Downloaded from http://bmjopen.bmj.com/ on January 7, 2022 by guest. Protected by copyright.

14 Tuite AR, Fisman DN, Greer AL. Mathematical modelling of COVID-19
transmission and mitigation strategies in the population of Ontario,
Canada. CMAJ 2020;192:E497–505.
15 Wells CR, Fitzpatrick MC, Sah P, et al. Projecting the demand for
ventilators at the peak of the COVID-19 outbreak in the USA. Lancet
Infect Dis 2020;20:1123–5.
16 Roberts M, Russell LB, Paltiel AD, et al. Conceptualizing a model: a
report of the ISPOR-SMDM modeling good research practices task
Force-2. Med Decis Making 2012;32:678–89.
17 Briggs AH, Weinstein MC, Fenwick EAL, et al. Model parameter
estimation and uncertainty analysis: a report of the ISPOR-SMDM
modeling good research practices Task force working Group-6. Med
Decis Making 2012;32:722–32.
18 Marmot M. Social determinants of health inequalities. The Lancet
2005;365:1099–104.
19 Mauskopf J. Multivariable and structural uncertainty analyses for
cost-effectiveness estimates: back to the future. Value Health
2019;22:570–4.

